AnandV., DuarteB., BrunsmannF., et al. (2003). Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus. Vision Res., 43, 919–926.
2.
BennettJ., AshtariM., WellmanJ., et al. (2012). AAV2 gene therapy readministration in three adults with congenital blindness. Sci. Transl. Med., 14, 120ra15.
3.
BennicelliJ., WrightJ.F., KomaromyA., et al. (2008). Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol. Ther., 16, 458–465.
4.
CoussaR.G., KimJ., and TraboulsiE.I. (2012). Choroideremia: effect of age on visual acuity in patients and female carriers. Ophthalmic Genet., 33, 66–73.
5.
CremersF., BrunsmannF., BergerW., et al. (1990). Cloning of the breakpoints of a deletion associated with choroideremia. Hum. Genet., 86, 61–64.
6.
JacobsonS.G., CideciyanA.V., RatnakaramR., et al. (2012). Gene Therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch. Ophthalmol., 130, 9–24.
7.
MaclarenR., GroppeM., BarnardA., et al (2014). Initial observations in patients undergoing retinal gene therapy for choroideremia. The Lancet. [Epub ahead of print] DOI: 10.1016/50140-6736(13)62117-0
8.
MaguireA.M., SimonelliF., PierceE.A., et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med., 358, 2240–2248.
9.
MaguireA.M., HighK.A., AuricchioA., et al. (2009). Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet, 374, 1597–1605.
10.
SeabraM.C., BrownM.S., and GoldsteinJ.L. (1993) Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase. Science, 259, 377–381.
11.
TolmachovaT., TolmachovO.E., Wavre-ShaptonS.T., et al. (2012). CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice. J. Gene Med., 14, 158–168.
12.
TolmachovaT., TolmachovO.E., BarnardA.R., et al. (2013). Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo. J. Mol. Med. (Berl), 91, 825–837.
13.
Van BokhovenH., Van Den HurkJ., BogardL., et al. (1994). Cloning and characterization of the human choroideremia gene. Hum. Mol. Genet., 3, 1041–1046.
14.
VasireddyV., MillsJ.A., GaddameediR., et al. (2013). AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One, 8, e61396.
